ANTHONY MARION: Open Payments
NPI 1609313048 · BARNEGAT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 82 payments from 11 companies in 2025. Trend: 2023 $1,503 · 2024 $1,339 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $380 |
| Novartis Pharmaceuticals Corporation | 15 | $327 |
| Incyte Corporation | 18 | $314 |
| Organon LLC | 19 | $282 |
| Amgen Inc. | 3 | $233 |
| UCB, Inc. | 4 | $78 |
| Galderma Laboratories, L.P. | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 4 | $60 |
| Lilly USA, LLC | 2 | $39 |
| Krystal Biotech Inc | 1 | $16 |
Products named: OPZELURA, SKYRIZI, OTEZLA, Rhapsido, VTAMA, COSENTYX, RINVOQ, Bimzelx.
Industry payments across NJ — which companies pay providers there.
